State Key Laboratory of Oncology in South China, Guangzhou, China.
BMC Cancer. 2010 Oct 7;10:535. doi: 10.1186/1471-2407-10-535.
Locally advanced (pT3-4N0M0) hepatocellular carcinoma (HCC) is a heterogeneous group of tumors, which consists of four different categories, including HCC with "multiple tumors more than 5 cm", "major vascular invasion", "invasion of adjacent organs", and "perforation of visceral peritoneum". The aim of our study was to verify whether the 2002 version of the Tumor-Node-Metastasis staging system could predict surgical outcomes in patients with locally advanced HCC.
We retrospectively reviewed 298 patients with pT3-4N0M0 HCC who underwent hepatic resection from 1993 to 2000 in an academic tertiary hospital. Overall survival (OS) and cumulative recurrence rate (CRR) of the four categories of locally advanced HCC patients were compared.
In multivariate analysis, major vascular invasion was identified as the most significant factor (HR = 3.291, 95% CI 2.362-4.584, P < 0.001) followed by cirrhosis status on OS, and was found to be the only independent factor of CRR (HR = 2.242, 95% CI 1.811-3.358, P < 0.001) in patients with locally advanced HCC. Among the four categories of locally advanced HCC, OS was significantly worse, and CRR was significantly higher in patients with HCC with major vascular invasion (pT3) than with multiple tumors more than 5 cm (pT3); or tumor invasion of adjacent organs (pT4); or perforation of visceral peritoneum (pT4). No significant differences were observed in OS or CRR between the latter three groups of patients.
HCC with major vascular invasion, which are classified as pT3 under the current TNM staging, have the worst prognosis when compared with the other categories of pT3-4 disease. There is a need to redefine the T classification and to stratify locally advanced HCC.
局部进展期(pT3-4N0M0)肝细胞癌(HCC)是一组异质性肿瘤,包括四种不同类型,包括“多个肿瘤大于 5cm”、“主要血管侵犯”、“邻近器官侵犯”和“内脏腹膜穿孔”的 HCC。我们的研究旨在验证 2002 年版肿瘤-淋巴结-转移分期系统是否能预测局部进展期 HCC 患者的手术结局。
我们回顾性分析了 1993 年至 2000 年在一家学术性三级医院接受肝切除术的 298 例 pT3-4N0M0 HCC 患者。比较了四种局部进展期 HCC 患者的总生存率(OS)和累积复发率(CRR)。
多因素分析显示,主要血管侵犯是最重要的因素(HR=3.291,95%CI2.362-4.584,P<0.001),其次是 OS 时的肝硬化状态,是局部进展期 HCC 患者 CRR 的唯一独立因素(HR=2.242,95%CI1.811-3.358,P<0.001)。在四种局部进展期 HCC 中,伴有大血管侵犯(pT3)的 HCC 患者的 OS 显著较差,CRR 显著较高(pT3)比多个肿瘤大于 5cm(pT3);或肿瘤侵犯邻近器官(pT4);或内脏腹膜穿孔(pT4)。后三组患者的 OS 或 CRR 无显著差异。
目前 TNM 分期中归类为 pT3 的伴有大血管侵犯的 HCC 与其他 pT3-4 疾病相比预后最差。有必要重新定义 T 分期并对局部进展期 HCC 进行分层。